Bioproduction Congress 2023

Lyon, France

Quality Assistance will attend
the Bioproduction Congress 2023


The Bioproduction Congress is the annual event of the biopharmaceutical production sector. This event will bring together experts from companies and laboratories developing therapeutic candidates as well as leading bioproduction professionals to accelerate therapeutics drugs such as mAbsvaccinescell therapy and novel products into commercial manufacturing.


Cécile Montagne and Rémy Delmotte, Key Account Managers, will attend the conference. Make sure to exchange with them on the latest bioproduction trends and on your analytical needs at table 26.


Bioproduction Congres_Banner



Arnaud Delobel, R&D and Innovation Director, is member of the Scientific Advisory Board of the 8th edition Bioproduction Congress. He will present on "Is multi-attribute monitoring ready for QC? Insights from an interlaboratory study"


Talk Arnaud Delobel BIOPC



With more than 40 years’ experience, Quality Assistance has become a leader in analytical sciences and holds a unique position on the market with all its laboratories on one site and 250 highly qualified professionals. Quality Assistance centralises all analytical services on one site:


Monoclonal antibodies

Take no risk with your analytics when developing new therapeutic monoclonal antibodies. Our analytical teams take advantage of their extensive experience with the analysis of mAbs. Throughout non-clinical and clinical development, our experts provide you with the customised solutions in terms of analytical protocols and innovative technologies to help you move your product from discovery to the market place.


Whatever the type of antigen, Quality Assistance covers a wide range of analytical technologies needed to support vaccine development, including product characterisation, development and validation of analytical methods, stability studies, batch testing and bioanalysis to support immunogenicity and protection studies.


Quality Assistance offers extensive experience with analytical development and validation and GMP/GLP compliant laboratories to assist in the development of your cell-based medicinal products.

Viral vectors

Due to their complex structure and size, as well as a constantly evolving regulatory landscape, the physicochemical and biological characterisation of viral vector-based products is challenging.

Building on our considerable experience in the analysis of complex innovative drugs, Quality Assistance is continuously advancing ways to support the development of your products. We continuously invest in new technologies and machinery and are able to assist you in the development of your recombinant Adeno-Associated Viral Vectors products from early phases to marketing authorisation.

Register now to the event

More information on

To set-up a meeting with our team, fill in the form below